Hormonal Therapy and Radiation Therapy in Prostate Cancer: 5-Year Outcomes From a Trial Evaluating Combined Androgen Blockade With 5-Alpha Reductase Inhibitors as an Alternative to Gonadotropin Releasing Hormone Agonists.

Hormonal Therapy and Radiation Therapy in Prostate Cancer: 5-Year Outcomes From a Trial Evaluating Combined Androgen Blockade With 5-Alpha Reductase Inhibitors as an Alternative to Gonadotropin Releasing Hormone Agonists. Clin Genitourin Cancer. 2024 Aug; 22(4):102103.

View in: PubMed

subject areas

5-alpha Reductase Inhibitors
Aged
Aged, 80 and over
Androgen Antagonists
Antineoplastic Agents, Hormonal
Antineoplastic Combined Chemotherapy Protocols
Follow-Up Studies
Gonadotropin-Releasing Hormone
Humans
Leuprolide
Male
Prostatic Neoplasms
Quality of Life
Treatment Outcome

authors with profiles

Russell Z. Szmulewitz
Stanley Liauw
Sean Pitroda
Ted Skolarus
Scott E. Eggener